Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
marrow blast percentage | proportion of counted marrow cells identified as blasts | The marrow blast percentage was reported separately from the peripheral blood count. | Objective | Hematology and transfusion laboratory reporting |
measured concentration | value obtained directly by assay | The measured concentration is recorded separately from the modeled estimate. | Objective | Drug levels - analyte, specimen and reporting |
methemoglobin | hemoglobin containing oxidized ferric iron | The analyzer separately reports the methemoglobin fraction. | Objective | Electrolytes, acid-base and metabolic testing |
miliary pattern | diffuse pattern of tiny lung nodules | The chest imaging report describes a miliary pattern with the differential given separately in the report. | Objective | Thoracic imaging descriptions |
minimum bactericidal concentration | lowest concentration meeting the assay's defined bacterial killing endpoint | The minimum bactericidal concentration was listed separately from the minimum inhibitory concentration. | Objective | Molecular testing, serology and culture findings |
N-acetylprocainamide | active procainamide metabolite also called NAPA | The laboratory reports N-acetylprocainamide on a separate line from the parent drug. | Objective | Drug levels - named analytes and exposure reports |
nominal sampling time | planned or protocol time rather than the confirmed collection time | Nominal sampling time was listed separately from the actual phlebotomy time. | Assessment | Medication response, exposure and reconciliation |
nontarget lesion | disease site followed without inclusion in the target measurement total | Nontarget lesion was described separately from the measured lesions. | Assessment | Cancer, treatment response and transplant assessment |
paired biopsy specimens | two tissue samples designated for different assessments | Label the paired biopsy specimens separately with site and intended testing. | Plan | Procedure, specimen and wound plans |
part-solid nodule | lung nodule containing both hazy and solid components | The chest imaging report describes a part-solid nodule with the solid portion measured separately. | Objective | Thoracic imaging descriptions |
passive death wish | wish to be dead or not to wake up | The patient reports a passive death wish with active suicidal thoughts and intent assessed separately. | Subjective | Mood, thought, trauma and behavioral history |
pathophysiologic mechanism | functional process proposed to connect a cause with observed clinical findings | Pathophysiologic mechanism was outlined separately from the confirmed findings. | Assessment | Precision in clinical interpretation and documentation |
patient-controlled dose | dose triggered by the patient through a programmed delivery device | The patient-controlled dose was recorded separately from the continuous basal rate. | Objective | Vascular access and infusion observations |
plasma renin activity | measure of angiotensin I generation under specified assay conditions | Plasma renin activity was identified separately from a direct renin concentration. | Objective | Glucose monitoring, endocrine testing and urine studies |
podagra | acute inflammation at the first metatarsophalangeal joint classically associated with gout | The specialist records podagra with aspirate findings documented separately. | Objective | Muscle, joint fluid and inflammatory measurements |
polymicrobial bacteremia | more than one organism recovered from blood in the clinical episode | Polymicrobial bacteremia was documented with separate identification for each isolate. | Assessment | Infection course, epidemiology and source attribution |
Polysplenia | Multiple small spleens | Imaging demonstrated polysplenia with several separate splenic structures. | Objective | Imaging reports and anatomic findings |
procainamide | antiarrhythmic whose active metabolite may also be measured | The procainamide and metabolite concentrations are shown separately. | Objective | Drug levels - named analytes and exposure reports |
rectal tone | resistance or squeeze at the anal sphincter on examination | Resting rectal tone and voluntary squeeze are documented separately. | Objective | Abdomen, pelvis and genitourinary examination |
Recurrent cystitis | Recurrent bladder infections | The assessment includes recurrent cystitis with separate culture-confirmed episodes. | Assessment | Urinary and reproductive assessment |
Recurrent herpes | Repeated episodes of herpesvirus reactivation or disease | The assessment includes recurrent herpes with separate documented flares. | Assessment | Inflammatory, immune and endocrine assessment |
Recurrent otitis media | Recurrent middle ear infection | The assessment includes recurrent otitis media based on separate documented episodes. | Assessment | Ear, nose and airway assessment |
reference interval | laboratory comparison interval attached to a specified test | Record the laboratory reference interval separately from the patient-specific goal. | Plan | Drug levels - verification and documentation |
relapsing course | periods of recurrence after improvement | The relapsing course is documented by discrete episodes separated by recovery. | Assessment | Diagnostic reasoning and strength of evidence |
repeat level | new concentration from another collection | The repeat level was obtained by separate venipuncture. | Objective | Drug levels - collection and dose timing |